Argus Cognitive’s paediatric autism diagnostic secures FDA clearance
Argus Cognitive’s Neurora has secured US Food and Drug Administration (FDA) clearance, providing clinicians with a tool to support the …
Argus Cognitive’s Neurora has secured US Food and Drug Administration (FDA) clearance, providing clinicians with a tool to support the …
The US Food and Drug Administration (FDA) has approved Sonorous Neurovascular’s investigational device exemption (IDE) application for its venous sinus …
Clinical-stage company INBRAIN Neuroelectronics has reported outcomes from the Minimally Invasive Neuromodulation Implant and implantation procedure based on ground-breaking GRAPHene …
Dr Michael Suk, founder and CEO of MDEnvoy, outlines the issues and potential solutions to premium labour bidding practices in …
Becton, Dickinson and Company (BD) has reported nine-month clinical findings from the iliac cohort of its AGILITY Investigational Device Exemption …
Zenflow has raised $52m in a round led by Cook Medical to accelerate the commercialisation of its implant for an …
OXOS Medical has won a federal contract to develop a next-generation X-ray system, the portability of which could help during …
Epicore Biosystems has entered into a collaboration with the Middle East Cystic Fibrosis Association (MECFA) to develop its wearable microfluidic …
The UK National Health Service (NHS) Supply Chain has awarded £184m ($243.7m) tender to Cambridge Heartwear to supply its HeartSense …
Few technologies are changing any therapy as quickly as pulsed field ablation (PFA) in the cardiac ablation market. Market intelligence …
Science Corporation’s subretinal implant and specialised glasses combination, PRIMA, has been shown to provide durable, long-term gains in vision to …
Happy Health’s Happy Ring has secured US Food and Drug Administration (FDA) clearance for blood pressure measurement, making it the …
The UK government has opted to accept all the recommendations made by its specialist healthcare-focused artificial intelligence (AI) commission around …
Type 1 diabetes patients using MiniMed’s Smart Multiple Daily Injection (MDI) system who responded to more missed-dose and high-glucose alerts …
CellCarta has entered into a strategic partnership with Waters Corporation to develop companion diagnostic (CDx) and next-generation flow cytometry solutions …